|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.20 USD | -2.33% |
|
+0.55% | +40.50% |
| 06-29 | Celldex Therapeutics, Inc.(NasdaqCM:CLDX) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Celldex Therapeutics, Inc.(NasdaqCM:CLDX) added to Russell 2500 Growth Benchmark | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 39.93 | 39.93 | 42.56 |
| Spread/Res. | -4.43% | -4.43% | -10.34% |
| Spread/Supp. | +10.96% | +33.61% | +33.33% |
| Support | 34.39 | 28.56 | 28.62 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CLDX Stock
- Charts Celldex Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
